Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Asunción Beltrán Videla
Observed names:
A. Beltrán-Videla,
Asunción Beltrán-Videla,
María Asunción Beltrán Videla,
María Asunción Beltrán-Videla
Institutions:
Santa Lucía University General Hospital,
Instituto Murciano de Investigación Biosanitaria
Observed institutions:
Santa Lucía University General Hospital,
Instituto Murciano de Investigación Biosanitaria,
Hospital Universitario Virgen de la Arrixaca
ORCID:
0000-0002-1481-6559
Observed ORCID:
0000-0002-1481-6559
OpenAlex ID:
A5071237420
Docetaxel Resistance in Breast Cancer: Current Insights and Future Directions
2025
·
Fátima Postigo-Corrales
, Asunción Beltrán-Videla
, et al.
·
International Journal of Molecular Sciences
·
26
PDF
Effects of imipramine on cancer patients over-expressing Fascin1; description of the HITCLIF clinical trial
2023
·
Antonio Asensi-Cantó
, Edith Rodríguez-Braun
, et al.
·
Frontiers in Oncology
·
13
PDF
A Newborn Screening Program for Sickle Cell Disease in Murcia (Spain)
2023
·
María Sánchez-Villalobos
, Eulalia Campos Baños
, et al.
·
International Journal of Neonatal Screening
·
8
PDF
Whole Blood Transcriptome Analysis in Congenital Anemia Patients
2024
·
Maria Sanchez-Villalobos
, Eulalia Campos Baños
, et al.
·
International Journal of Molecular Sciences
·
3
PDF
Case Report: α-Spectrin Mutation Associated with αLELY Polymorphism Responsible for Hereditary Pyropoikilocytosis
2022
·
María Sánchez Villalobos
, Eduardo Salido Fiérrez
, et al.
·
Hematology Reports
·
1
PDF
Integrative microbiome–methylome analysis links bacterial taxa to colorectal cancer histological subtypes
2026
·
Ángel Escudero-Jiménez
, Jorge Galán-Ros
, et al.
·
mSystems
PDF
117eP Imipramine-induced transcriptomic reprogramming in breast cancer: A comparative analysis in luminal and triple-negative cell lines
2026
·
A. Izquierdo Martínez
, A. Beltrán-Videla
, et al.
·
ESMO Open
361eTiP HITCLIF. histological and clinical effects of imipramine in the treatment of patients with cancer over expressing fascin1
2026
·
A. Beltrán-Videla
, A. Asensi Cantó
, et al.
·
ESMO Open
PDF
97P Drug sensitivity prediction based on RNA expression profiling in colorectal cancer organoids
2025
·
A. Fahim
, L. Feist
, et al.
·
ESMO Open
PDF
Pb2382: Effects of Antifascin Compounds Against Lymphoma Cells in Vitro
2023
·
Ana María Hurtado López
, Daniel Chedas
, et al.
·
HemaSphere
Show more works
View as search
Works count:
10
Citation count:
51
H-index:
3
I10-index:
2
Year
Topic
Type